Similar Papers

Paper Title
Journal
Date
Author
Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
A K Sinha ... A K Rao
Proceedings of the National Academy of Sciences of the United States of America | VOL. 80
A K Sinha, et. al.A K Sinha ... A K Rao
01 Oct 1983
Enhanced arachidonic acid metabolism in alveolar macrophages from wheezy infants. Modulation by dexamethasone.
I Azevedo ... P Scheinmann
American Journal of Respiratory and Critical Care Medicine | VOL. 152
I Azevedo, et. al.I Azevedo ... P Scheinmann
01 Oct 1995
Suppression of foam cell lesions in hypercholesterolemic rabbits by inhibition of thromboxane A2 synthesis.
V A Skrinska ... R G Gerrity
Arteriosclerosis (Dallas, Tex.) | VOL. 8
V A Skrinska, et. al.V A Skrinska ... R G Gerrity
01 Jul 1988
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
S R Hanson ... L A Harker
Journal of Clinical Investigation | VOL. 75
S R Hanson, et. al.S R Hanson ... L A Harker
01 May 1985
View more papers

More From: Japanese Journal of Pharmacology

Paper Title
Journal
Date
Author
The Distribution of Tax Incentives
Japanese Journal of Pharmacology | VOL. -
10 Aug 2015
THE ENDOWMENT EFFECT AND EMOTIONS: POSSESSION TRUMPS PASSION
Japanese Journal of Pharmacology | VOL. -
01 Jan 2009
Inhibitory Effect of the Water-Soluble Extract of Salvia miltiorrhiza on Neutrophil-Endothelial Adhesion
De Cheng Ren ... Jun Tian Zhang
Japanese Journal of Pharmacology | VOL. 90
De Cheng Ren, et. al.De Cheng Ren ... Jun Tian Zhang
01 Jan 2002
Characteristics of ATP-Induced Current Through P2X7 Receptor in NG108-15 Cells: Unique Antagonist Sensitivity and Lack of Pore Formation
Tomokazu Watano ... Junko Kimura
Japanese Journal of Pharmacology | VOL. 88
Tomokazu Watano, et. al.Tomokazu Watano ... Junko Kimura
01 Jan 2002
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.